<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03350516</url>
  </required_header>
  <id_info>
    <org_study_id>OPP1172660</org_study_id>
    <nct_id>NCT03350516</nct_id>
  </id_info>
  <brief_title>Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy</brief_title>
  <official_title>Demonstrating Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy for Reducing Preeclampsia and Neonatal Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. John's Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ifakara Health Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Africa Academy for Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The World Health Organization currently recommends that pregnant women in populations with
      low calcium intake receive daily calcium supplementation (1500 - 2000 mg) divided into three
      doses which are preferably taken at mealtimes, in addition to daily iron folic-acid
      supplements. Despite proven efficacy and the WHO recommendation, calcium supplementation in
      pregnancy is not standard of care in the vast majority of low-income and middle-income
      countries. Two important barriers to implementation are the cost of the supplements and
      complexity of the suggested calcium dosing schedule. A lower dose of calcium (500 mg)
      administered as a single dose has been shown to be beneficial in several trials, and if found
      to be as effective as the 1500 mg supplementation regimen, it may help overcome these
      barriers and increase individual and health system adoption.

      The Investigators will conduct two parallel, individually randomized, double blind
      non-inferiority trials in India and Tanzania. Participating pregnant woman will be randomized
      to either 1500 mg or 500 mg calcium supplementation. The India and Tanzania trials are
      independently powered for the primary outcomes of i) preeclampsia and ii) preterm birth. The
      India and Tanzania sites will each enroll 11,000 participants.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2018</start_date>
  <completion_date type="Anticipated">October 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of pregnant women with incident preeclampsia</measure>
    <time_frame>Gestational week 20 to Delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of preterm birth</measure>
    <time_frame>Birth</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22000</enrollment>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Daily 500 mg Calcium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Daily1500 mg Calcium (Standard dose)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Daily 500 mg elemental calcium as calcium carbonate</intervention_name>
    <description>Pregnant women in this arm will be provided and counselled to take three tablets, one containing 500 mg elemental calcium as calcium carbonate and 2 placebo supplements daily (total of 500 mg daily). The supplements in India will also contain 83.3 IU each of vitamin D3, for a total of 250 IU daily. No vitamin D3 will be given in Tanzania.</description>
    <arm_group_label>Daily 500 mg Calcium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Daily1500 mg elemental calcium as calcium carbonate</intervention_name>
    <description>Pregnant women in this arm will be provided and counselled to take three tablets each containing 500 mg elemental calcium as calcium carbonate daily (total of 1500 mg daily) as currently recommended by the World Health Organization. The supplements in India will also contain 83.3 IU each of vitamin D3, for a total of 250 IU daily. No vitamin D3 will be given in Tanzania.</description>
    <arm_group_label>Daily1500 mg Calcium (Standard dose)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparous

          -  Attending first ANC visit at study clinics

          -  Pregnant women &lt;20 weeks

          -  â‰¥ 18 years old

          -  Intending to stay in study area until 6 weeks post delivery

          -  Provides informed consent

        Exclusion Criteria:

          -  History or signs and/or symptoms of nephrolithiasis

          -  Prior diagnosis of parathyroid disorder or thyroidectomy

          -  Diseases that require digoxin, phenytoin, or tetracycline therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wafaie W Fawzi, MBBS, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard T.H. Chan School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wafaie W Fawzi, MBBS, DrPH</last_name>
    <phone>617-432-5299</phone>
    <email>mina@hsph.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christopher R Sudfeld, ScD</last_name>
    <phone>617-432-5051</phone>
    <email>csudfeld@hsph.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St. John's Research Institute</name>
      <address>
        <city>Bangalore</city>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anura Kurpad, MD, PhD</last_name>
      <email>a.kurpad@sjri.res.in</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Africa Academy for Public Health</name>
      <address>
        <city>Dar Es Salaam</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mary Mwanyika-Sando, MD, MPH</last_name>
      <email>mmwanyika.sando@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ifakara Health Institute</name>
      <address>
        <city>Dar Es Salaam</city>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Honorati Masanja, PhD</last_name>
      <email>hmasanja@ihi.or.tz</email>
    </contact>
  </location>
  <location_countries>
    <country>India</country>
    <country>Tanzania</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2017</study_first_submitted>
  <study_first_submitted_qc>November 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2017</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard School of Public Health</investigator_affiliation>
    <investigator_full_name>Wafaie Fawzi</investigator_full_name>
    <investigator_title>Richard Saltonstall Professor of Population Sciences, Professor of Nutrition, Epidemiology, and Global Health, Chair of the Department of Global Health and Population</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

